Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 51 $ 60
Prepaid expenses 27 30
Total Current Assets 78 90
Intangible assets 25,262 25,262
Deposits 12 12
Operating lease right-to-use asset 153 0
Fixed assets, net 34 35
Total Other Assets 25,461 25,309
TOTAL ASSETS 25,539 25,399
Current Liabilities:    
Accounts payable 1,898 1,762
Accrued expenses 2,136 1,455
Deferred rent 0 8
Operating lease liability 161 0
Note payable to related party 0 100
Line of credit 31 31
Convertible debentures 11,297 10,673
Total Current Liabilities 15,523 14,029
Total liabilities 15,523 14,029
Stockholders' Equity:    
Common stock - $0.001 par value; 750,000,000 shares authorized; and 51,374,417 and 50,650,478 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively 51 51
Additional paid-in capital 543,327 540,171
Accumulated deficit (533,195) (528,685)
Noncontrolling interest (169) (169)
Total Stockholders' Equity 10,016 11,370
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 25,539 25,399
Series C    
Stockholders' Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: 1 1
Series J    
Stockholders' Equity:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: $ 1 $ 1